Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Closed Date6/2012

General Information

Offices

Headquarters
158 Credle Street
Pittsboro, NC, 27312
USA

People

Board of Directors
Director
Director

Funding

Tags

Biolex Therapeutics Closed down June, 2012

Biolex Therapeutics

Biolex is a clinical-stage biopharmaceutical company that uses their patented LEX SystemSM to develop hard-to-make therapeutic proteins and monoclonal antibodies that have been optimized to enhance their efficacy and potency. The LEX System is a technology that genetically transforms the aquatic plant Lemna to enable the production of biologic product candidates. Their main product aims at treating those afflicted with Hepatitis C.

Recent Milestones

Videos

Screenshots

Biolex Therapeutics screenshot
Above: Biolex Therapeutics Screenshot -- #1
Uploaded: 6/22/09

Sources

  1. EDGAR [edit]
  2. BIOLEX THERAPEUTICS RAISES $36 MILLION IN VENTURE FINANCING (biolex.com) [edit]
  3. BIOLEX THERAPEUTICS RAISES $30 MILLION TO ADVANCE ITS HEPATITIS C DRUG CANDIDATE AND OTHER PIPELINE PROGRAMS (biolex.com) [edit]
  4. Biolex Therapeutics Completes $60 Million Series D Financing to Accelerate Development of Locteron® in Hepatitis C (mitsuiventures.com) [edit]
  5. SEC (sec.gov) [edit]
  6. Biolex Gets $20M From Insiders, Sees Strong Data From Hepatitis C Drug (fis.dowjones.com) [edit]
  7. S (sec.gov) [edit]
  8. SEC (sec.gov) [edit]
Edit This Page
Last Edited 12/18/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy